Current and Future Developments in Hypertension

Current and Future Developments in Hypertension

Novel Strategies and Approaches in Hypertension Therapy

INTRODUCTION: Hypertension has become a major public health problem in the last few decades. High blood pressure is a serious risk factor for premature cardiovascular disease and end-organ damage ...
[view complete introduction]

US $
30

*(Excluding Mailing and Handling)



Endocrinal Hypertension and Hyperaldosteronism: Biochemical and Genetic Aspects of Adrenal Dependent Endocrinal Hypertension

Pp. 201-225 (25)

Sinem Durmus and Hafize Uzun

Abstract

Endocrine causes of secondary hypertension include pheochromocytoma, hyperdeoxycorticosteronism, Cushing’s syndrome, apparent mineralocorticoid excess/11ß-hydroxysteroid dehydrogenase deficiency and primary aldosteronism. They comprise of the 5-10% of the causes of secondary hypertension. The identification of the genetic determinants of hypertension has been most successful in endocrine forms of hypertension. Moreover, the latest discoveries in molecular pathogenesis of these disease will provide an important basis for future personalized therapy. A promising area for the application of genetic testing to personalized therapy is the prediction of responses and adverse reactions to antihypertensive drugs. Herein, we review the different forms of endocrine hypertension, with a focus on prevalence and human genetic studies of endocrine causes of secondary hypertension, focusing on the most prominent and latest discovered genes; and related biochemical pathways reported in the literature.

Keywords:

Apparent mineralocorticoid excess/11ß-hydroxysteroid dehydrogenase deficiency Cushing’s syndrome, Biochemical findings, Endocrinal Hyper-tension, Genetic testing, Hypertension, Hyperdeoxycorticosteronism, Pheochro-mocytoma, Primary aldosteronism, Prevalence, Secondary hypertension.

Affiliation:

Department of Biochemistry, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.